Mortaza Raeisi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mortaza Raeisi has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Mojtaba Zehtabi
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publicationsSepehr Valizadeh
Tabriz Univ Med Sci, Sch Med, Dept Internal Med, Tabriz, Iran
2 shared publications- Seyed Ali Mousavi Aghdas
Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications Zahra Akbarpour
Tabriz Univ Med Sci, Rahat Breathe & Sleep Res Ctr, Tabriz, Iran
2 shared publications- Ahmadali Khalili
Department of Cardiovascular Surgery, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication Ali Akabr Movassaghpour Akbari
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- 4 August 2026
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 14
High-Risk and Low-Risk Human Papillomavirus (HPV) Virus Distribution in Symptomatic and Asymptomatic Population: a Cross-Sectional Study
Introduction: Human papillomavirus (HPV) infection is associated with both sexes’ oropharyngeal and anogenital warts and malignancies. This virus has several genotypes, including high-risk and low-risk subtypes. Some genotypes are less known. This study investigated the prevalence of HPV genotypes, which could lead to the development of more effective vaccines and preventive strategies. Methods: A total of 851 samples, including 693 swabs of Pap Smear and 158 skin lesions from genital warts were analyzed by polymerase chain reaction (PCR)-Hybridization method to determine 19 high-risk and 18 low-risk HPV genotypes. Results: The participants’ mean age was 34.58±8.44, and most of them were between 31 to 40 years old. Totally, 257 participants (30.2%) tested positive for HPV; of these, 181 (21.2%) were positive for a single HPV subtype and 76 (8.9%) were infected by two or more HPV subtypes. The most frequent high-risk genotypes were HPV 16, 51, 56, and 66 in women and HPV 51, 16, 66, and 39 in men. Most frequent low-risk genotypes belonged to HPV 6, 11, 42, and 91. Moreover, HPV16 was the most prevalent high-risk HPV, especially when combined with genotype 52. Conclusion: Due to the majority of HPV-positive results, men play a significant role. It is suggested that men and women should receive intensive education on prevention and vaccination, with an emphasis on younger generations. Research on HPV in men, accompanied by women’s screening and routine vaccination in both genders, may be beneficial in reducing the consequences of this infection.
- 4 August 2026
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 14
High-Risk and Low-Risk Human Papillomavirus (HPV) Virus Distribution in Symptomatic and Asymptomatic Population: a Cross-Sectional Study
Introduction: Human papillomavirus (HPV) infection is associated with both sexes’ oropharyngeal and anogenital warts and malignancies. This virus has several genotypes, including high-risk and low-risk subtypes. Some genotypes are less known. This study investigated the prevalence of HPV genotypes, which could lead to the development of more effective vaccines and preventive strategies. Methods: A total of 851 samples, including 693 swabs of Pap Smear and 158 skin lesions from genital warts were analyzed by polymerase chain reaction (PCR)-Hybridization method to determine 19 high-risk and 18 low-risk HPV genotypes. Results: The participants’ mean age was 34.58±8.44, and most of them were between 31 to 40 years old. Totally, 257 participants (30.2%) tested positive for HPV; of these, 181 (21.2%) were positive for a single HPV subtype and 76 (8.9%) were infected by two or more HPV subtypes. The most frequent high-risk genotypes were HPV 16, 51, 56, and 66 in women and HPV 51, 16, 66, and 39 in men. Most frequent low-risk genotypes belonged to HPV 6, 11, 42, and 91. Moreover, HPV16 was the most prevalent high-risk HPV, especially when combined with genotype 52. Conclusion: Due to the majority of HPV-positive results, men play a significant role. It is suggested that men and women should receive intensive education on prevention and vaccination, with an emphasis on younger generations. Research on HPV in men, accompanied by women’s screening and routine vaccination in both genders, may be beneficial in reducing the consequences of this infection.
- 12 March 2025
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 24 (2) , 254-258
Association between IFN‐γ +874T/A SNP and COVID-19 Severity
The severity of coronavirus disease 2019 (COVID-19) varies significantly among individuals, which indicates the impact of individual differences on disease. Emerging evidence suggests that genetic factors play a crucial role in determining the severity of the disease. For instance, variants in the interferon-gamma (IFN-γ) gene, such as the +874 T/A single nucleotide polymorphism (SNP), have been linked to altered immune responses and may influence the severity of COVID-19. We aim to determine the influence of the IFN‐γ +874T/A SNP on the clinical outcomes of COVID-19 patients. We investigated the SNP at position +874 in the promoter region of the IFN-γ gene in 416 individuals (206 critically ill COVID-19 patients and 210 healthy controls) in northwestern of Iran. Genomic DNA was extracted from the blood leukocytes of the patients, and the SNP was analyzed using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) method. The AA genotype was significantly more frequent in critically ill COVID-19 patients than in healthy controls. Conversely, the AT and TT genotypes were more common in healthy controls. Furthermore, the A allele was more frequent in critically ill patients than in healthy controls, while the T allele was more frequent in healthy controls compared to critically ill patients. Our study identified the IFN-γ +874T/A SNP as a significant genetic factor influencing COVID-19 severity. This finding underscores the critical role of genetic factors in disease severity and highlights the importance of personalized medicine in managing COVID-19.
- 12 March 2025
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 24 (2) , 254-258
Association between IFN‐γ +874T/A SNP and COVID-19 Severity
The severity of coronavirus disease 2019 (COVID-19) varies significantly among individuals, which indicates the impact of individual differences on disease. Emerging evidence suggests that genetic factors play a crucial role in determining the severity of the disease. For instance, variants in the interferon-gamma (IFN-γ) gene, such as the +874 T/A single nucleotide polymorphism (SNP), have been linked to altered immune responses and may influence the severity of COVID-19. We aim to determine the influence of the IFN‐γ +874T/A SNP on the clinical outcomes of COVID-19 patients. We investigated the SNP at position +874 in the promoter region of the IFN-γ gene in 416 individuals (206 critically ill COVID-19 patients and 210 healthy controls) in northwestern of Iran. Genomic DNA was extracted from the blood leukocytes of the patients, and the SNP was analyzed using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) method. The AA genotype was significantly more frequent in critically ill COVID-19 patients than in healthy controls. Conversely, the AT and TT genotypes were more common in healthy controls. Furthermore, the A allele was more frequent in critically ill patients than in healthy controls, while the T allele was more frequent in healthy controls compared to critically ill patients. Our study identified the IFN-γ +874T/A SNP as a significant genetic factor influencing COVID-19 severity. This finding underscores the critical role of genetic factors in disease severity and highlights the importance of personalized medicine in managing COVID-19.
- Open Access
- 26 February 2024
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
Hsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups
Background. Recurrent pregnancy loss is defined as at least two consecutive clinical pregnancy losses before 20th week of gestation. In this study, we investigated microRNA-1 and microRNA-1229 in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control group. Methods. First, a written and informed consent will be obtained from the target population of this study, who are people with RPL referring to Waliasr International Hospital. According to the standard protocol, the number of 2×107 is injected subcutaneously to patients. Real-time PCR technique will be used to check the expression level of microRNA-1 and microRNA-1229. Results. The gene expression level of micro-RNA 1 in RPL women before of lymphocyte therapy was 2.030±1.445 and the gene expression level of the same micro-RNA after the lymphocyte therapy of the mother was 1.101±0.4780. Also, the expression level of micro-RNA 1229 in these women was reported to be 2.100±0.6296 before treatment and 1.247±0.9631 after treatment with lymphocytes. This level of gene expression in control group, for micro-RNA 1 and micro-RNA 1229 genes is 1.000±0.08334 and 1.000±0.08091, respectively. Conclusion. The results of our study showed a noticeable decrease in the gene expression of microRNAs under study, both microRNAs 1 and 1229, in women with a history of three consecutive injections of the father's subcutaneous lymphocytes. Practical Implications. This study can show the therapeutic effect of lymphocyte for patients with recurrent miscarriage so that this treatment can be used along with other treatment methods.
- 26 February 2024
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
Open AccessHsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups
Background. Recurrent pregnancy loss is defined as at least two consecutive clinical pregnancy losses before 20th week of gestation. In this study, we investigated microRNA-1 and microRNA-1229 in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control group. Methods. First, a written and informed consent will be obtained from the target population of this study, who are people with RPL referring to Waliasr International Hospital. According to the standard protocol, the number of 2×107 is injected subcutaneously to patients. Real-time PCR technique will be used to check the expression level of microRNA-1 and microRNA-1229. Results. The gene expression level of micro-RNA 1 in RPL women before of lymphocyte therapy was 2.030±1.445 and the gene expression level of the same micro-RNA after the lymphocyte therapy of the mother was 1.101±0.4780. Also, the expression level of micro-RNA 1229 in these women was reported to be 2.100±0.6296 before treatment and 1.247±0.9631 after treatment with lymphocytes. This level of gene expression in control group, for micro-RNA 1 and micro-RNA 1229 genes is 1.000±0.08334 and 1.000±0.08091, respectively. Conclusion. The results of our study showed a noticeable decrease in the gene expression of microRNAs under study, both microRNAs 1 and 1229, in women with a history of three consecutive injections of the father's subcutaneous lymphocytes. Practical Implications. This study can show the therapeutic effect of lymphocyte for patients with recurrent miscarriage so that this treatment can be used along with other treatment methods.
- 1 January 2024
- Published by Pleiades Publishing Ltd in Russian Journal of Electrochemistry
- Vol. 60 (1) , 73-90
Diagnosis of Blood Gastric Cancer Biomarkers via Nanomaterial-Based Electrochemical Immunosensor: A Review on Recent Advancements (A Review)
Gastric cancer (GC) is one of the considered enormously important cancer types in the world. A large number of mortality rates have revealed that there is a massive shortage in the prognosis and treatment of GC because the majority of GC cases are identified at an advanced stage. In this regard, the rapid platform for non-invasive detection of GC cells through the analysis of GC biomarkers in the first stages with high sensitivity is essential for the success in the treatment of GC. In recent years, different types of electrochemical immunosensors as efficient sensing devices with benefits including accuracy, reproducibility and low cost have played an extremely significant role in the monitoring of GC. One of the significant issues in the development of electrochemical immunosensors is to increase the system’s sensitivity. A variety of nanomaterials based on carbon-based, silica-based and metallic-based nanomaterials have been used as sensing platforms on the different types of electrochemical electrodes for improving the properties of biodevices. This review highlighted the new progress and technical breakthroughs comprising electrochemical immunosensor for the determination of GC biomarkers including CA19-9, CA72-4, CA125 and CEA. In diverse matrices and proved how nanoprobes could enhance the performance of electrochemical immunsensing approaches.
- 1 January 2024
- Published by Pleiades Publishing Ltd in Russian Journal of Electrochemistry
- Vol. 60 (1) , 73-90
Diagnosis of Blood Gastric Cancer Biomarkers via Nanomaterial-Based Electrochemical Immunosensor: A Review on Recent Advancements (A Review)
Gastric cancer (GC) is one of the considered enormously important cancer types in the world. A large number of mortality rates have revealed that there is a massive shortage in the prognosis and treatment of GC because the majority of GC cases are identified at an advanced stage. In this regard, the rapid platform for non-invasive detection of GC cells through the analysis of GC biomarkers in the first stages with high sensitivity is essential for the success in the treatment of GC. In recent years, different types of electrochemical immunosensors as efficient sensing devices with benefits including accuracy, reproducibility and low cost have played an extremely significant role in the monitoring of GC. One of the significant issues in the development of electrochemical immunosensors is to increase the system’s sensitivity. A variety of nanomaterials based on carbon-based, silica-based and metallic-based nanomaterials have been used as sensing platforms on the different types of electrochemical electrodes for improving the properties of biodevices. This review highlighted the new progress and technical breakthroughs comprising electrochemical immunosensor for the determination of GC biomarkers including CA19-9, CA72-4, CA125 and CEA. In diverse matrices and proved how nanoprobes could enhance the performance of electrochemical immunsensing approaches.
- Open Access
- 1 April 2023
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 24 (4) , 1407-1411
Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients
Background: Non-small-cell lung cancer (NSCLC) is currently the leading cause of mortality cancer. Introducing noninvasive approaches to diagnose NSCLC, especially at an early phase, might improve the disease’s prognosis. Long noncoding RNAs (lncRNAs), which are important regulators of the expression genes inside the cells, have been linked to a range of biological processes, such as cancer progression and metastasis, including NSCLC. The present work aims to determine the potential involvement of SIK-1-LNC and SIK-1 in NSCLC pathogenesis and the possible use of these molecules as novel biomarkers or therapeutic targets. Methods: In this work, the expression levels of SIK-1-LNC and SIK-1 in 50 pairs of NSCLC tumor and tumor marginal tissues were evaluated. So, after total RNA extraction and complementary DNA synthesis, the SIK-1-LNC and SIK-1 expression levels were evaluated by real-time PCR. In the study groups, clinical and pathological characteristics of the NSCLC patients were also examined. Results: Our findings showed that tumor samples had much lower levels of SIK-1 and SIK-1-LNC expression than tumor margin samples. SIK-1-LNC expression was correlated with SIK-1 levels in NSCLC samples. Interestingly, both stage and lymph node metastasis features of the tumor were associated significantly with SIK-1 and SIK-1-LNC expression levels. A ROC curve analysis indicated a biomarker index of 0.69 and 0.74 for SIK-1 and SIK-1-LNC, respectively. Conclusion: Collectively, our study emphasized the role of SIK-1-LNC and SIK-1 downregulation in NSCLC oncogenesis. Additionally, SIK-1 and SIK-1-LNC, particularly the latter, have shown remarkable potential to be utilized as new NSCLC biomarkers and therapeutic targets.
- 1 April 2023
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 24 (4) , 1407-1411
Open AccessDown-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients
Background: Non-small-cell lung cancer (NSCLC) is currently the leading cause of mortality cancer. Introducing noninvasive approaches to diagnose NSCLC, especially at an early phase, might improve the disease’s prognosis. Long noncoding RNAs (lncRNAs), which are important regulators of the expression genes inside the cells, have been linked to a range of biological processes, such as cancer progression and metastasis, including NSCLC. The present work aims to determine the potential involvement of SIK-1-LNC and SIK-1 in NSCLC pathogenesis and the possible use of these molecules as novel biomarkers or therapeutic targets. Methods: In this work, the expression levels of SIK-1-LNC and SIK-1 in 50 pairs of NSCLC tumor and tumor marginal tissues were evaluated. So, after total RNA extraction and complementary DNA synthesis, the SIK-1-LNC and SIK-1 expression levels were evaluated by real-time PCR. In the study groups, clinical and pathological characteristics of the NSCLC patients were also examined. Results: Our findings showed that tumor samples had much lower levels of SIK-1 and SIK-1-LNC expression than tumor margin samples. SIK-1-LNC expression was correlated with SIK-1 levels in NSCLC samples. Interestingly, both stage and lymph node metastasis features of the tumor were associated significantly with SIK-1 and SIK-1-LNC expression levels. A ROC curve analysis indicated a biomarker index of 0.69 and 0.74 for SIK-1 and SIK-1-LNC, respectively. Conclusion: Collectively, our study emphasized the role of SIK-1-LNC and SIK-1 downregulation in NSCLC oncogenesis. Additionally, SIK-1 and SIK-1-LNC, particularly the latter, have shown remarkable potential to be utilized as new NSCLC biomarkers and therapeutic targets.
- 1 September 2022
- Vol. 11 (3) , 133-141
Upregulation of miR-142 in papillary thyroid carcinoma tissues: a report based on in silico and in vitro analysis
Papillary thyroid carcinoma (PTC) accounts for approximately 80% of all human thyroid malignancies. Recently, there has been a dramatic rise in the prevalence of thyroid cancer all over the globe. Through analysis of the GEO database, GSE104005, the authors of the current research were able to determine the differential expression of microRNAs (DEMs) as well as their target genes. Real-time PCR was used on a total of 40 samples, 40 of which were from PTC samples and 40 from normal tissues, in order to validate the discovered DEMs and the genes. Gene Ontology (GO) categories were identified, and KEGG was used to conduct pathway enrichment analysis. The multiMiR R package was used to predict target genes of DEMs. Mir-142 was found to be overexpressed in PTC samples, as compared to normal tissues, and this was validated by the identification and validation. In addition, metal ion binding and the cellular response to metal ions were identified as essential pathways in the carcinogenesis of PTC. This demonstrates their significance in the development of this malignancy. The results of our research will serve as the foundation for further research in the area of miRNA-based cancer treatment.
- 1 September 2022
- Vol. 11 (3) , 133-141
Upregulation of miR-142 in papillary thyroid carcinoma tissues: a report based on in silico and in vitro analysis
Papillary thyroid carcinoma (PTC) accounts for approximately 80% of all human thyroid malignancies. Recently, there has been a dramatic rise in the prevalence of thyroid cancer all over the globe. Through analysis of the GEO database, GSE104005, the authors of the current research were able to determine the differential expression of microRNAs (DEMs) as well as their target genes. Real-time PCR was used on a total of 40 samples, 40 of which were from PTC samples and 40 from normal tissues, in order to validate the discovered DEMs and the genes. Gene Ontology (GO) categories were identified, and KEGG was used to conduct pathway enrichment analysis. The multiMiR R package was used to predict target genes of DEMs. Mir-142 was found to be overexpressed in PTC samples, as compared to normal tissues, and this was validated by the identification and validation. In addition, metal ion binding and the cellular response to metal ions were identified as essential pathways in the carcinogenesis of PTC. This demonstrates their significance in the development of this malignancy. The results of our research will serve as the foundation for further research in the area of miRNA-based cancer treatment.
- 6 October 2021
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 53 (4) , 1040-1049
Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma
Purpose Esophageal cancer is the second most common cancer among men and women. There is a need to systematically assess the current evidence to map out the contribution of genetic factors in the development of esophageal squamous cell carcinoma (ESCC). Methods A literature search was carried out on published and unpublished studies up to August 2021 in Medline (PubMed), Embase (Ovid), Scopus, Proquest, Web of Science, and Google scholar. Studies that have reported the frequency of genetic mutations in ESCC were included in this study. Results A total of 1238 titles were retrieved through searches, and finally, 56 articles, including 8114 samples, met our predefined inclusion criteria. Of the included studies, 31 were conducted in China, 12 in Japan, and the remaining were conducted in various nations, including Brazil, Korea, and Iran. Most of our included studies evaluated the TP53 (n = 37 studies) and PIK3CA (n = 30 studies) gene mutations. TP53 (68.6%; 95% CI: 61.6–74.9), CCND1 (39.3%; 95% CI: 26.2–54.1), MDM2 (24.9%; 95% CI: 9.5–51.0), NOTCH1/2/3 (17.9%; 95% CI: 15.0–21.2), KMT2D (17.4%; 95% CI: 12.4–23.8), CDKN2A (15.0%; 95% CI: 8.1–26.1), PIK3CA (13.8%; 95% CI: 10.3–18.1), FAT1 (13.3%; 95% CI: 11.7–15.0), and EGFR (9.9%; 95% CI: 5.6–17.0) were the most common involved genetic factors in developing ESCC. Conclusion This systematic review and meta-analysis revealed that more than 10% of ESCC patients had changes in TP53, CCND1, MDM2, NOTCH1/2/3, KMT2D, CDKN2A, PIK3CA, and FAT1 genes, which can highlight their role in developing ESCC. TP53, CCND1, and MDM2 are the most prevalent, demonstrating 68.6%, 39.3%, and 24.9% of the mutations in ESCC patients.
- 6 October 2021
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 53 (4) , 1040-1049
Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma
Purpose Esophageal cancer is the second most common cancer among men and women. There is a need to systematically assess the current evidence to map out the contribution of genetic factors in the development of esophageal squamous cell carcinoma (ESCC). Methods A literature search was carried out on published and unpublished studies up to August 2021 in Medline (PubMed), Embase (Ovid), Scopus, Proquest, Web of Science, and Google scholar. Studies that have reported the frequency of genetic mutations in ESCC were included in this study. Results A total of 1238 titles were retrieved through searches, and finally, 56 articles, including 8114 samples, met our predefined inclusion criteria. Of the included studies, 31 were conducted in China, 12 in Japan, and the remaining were conducted in various nations, including Brazil, Korea, and Iran. Most of our included studies evaluated the TP53 (n = 37 studies) and PIK3CA (n = 30 studies) gene mutations. TP53 (68.6%; 95% CI: 61.6–74.9), CCND1 (39.3%; 95% CI: 26.2–54.1), MDM2 (24.9%; 95% CI: 9.5–51.0), NOTCH1/2/3 (17.9%; 95% CI: 15.0–21.2), KMT2D (17.4%; 95% CI: 12.4–23.8), CDKN2A (15.0%; 95% CI: 8.1–26.1), PIK3CA (13.8%; 95% CI: 10.3–18.1), FAT1 (13.3%; 95% CI: 11.7–15.0), and EGFR (9.9%; 95% CI: 5.6–17.0) were the most common involved genetic factors in developing ESCC. Conclusion This systematic review and meta-analysis revealed that more than 10% of ESCC patients had changes in TP53, CCND1, MDM2, NOTCH1/2/3, KMT2D, CDKN2A, PIK3CA, and FAT1 genes, which can highlight their role in developing ESCC. TP53, CCND1, and MDM2 are the most prevalent, demonstrating 68.6%, 39.3%, and 24.9% of the mutations in ESCC patients.
- Open Access
- 20 August 2021
- Published by Springer Nature in Research Square
Estimation of Autophagy Activity By Evaluating Possible MicroRNA Biomarkers and FOXO1 mRNA Level in Papillary Thyroid Carcinoma
Background: Papillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy. Despite nearly three-fold increase in incidence over three decades, the mortality rate remains unchanged. Biomarkers related to early diagnosis and prognosis of PTC are poorly investigated. Autophagy pathways and related miRNAs is considered to play an important role in PTC pathophysiology.Methods and Results: Tissue samples from patients with PTC undergoing thyroidectomy were collected. Total RNA content of tumor and margin samples were purified and converted to cDNA. Gene expression levels of mRNA (FOXO1) and miRNAs (miR-30d-5p, miR- 182-5p and miR-183-5p) were evaluated using qPCR method in PTC and adjacent normal tissue. A 6.51-fold decrease in miR-30d-5p level was detected in tumor samples compared to adjacent tissues. Moreover, miR-182-5p and miR-183-5p (FOXO1 as the main target) showed 1.73- and 4.31-fold increases in their levels, respectively. We also observed a 2.66-fold decrease in FOXO1 mRNA level in relation to these miRNA fold changes indicating a possible correlation between autophagy-linked molecular events and PTC.Conclusions: Significant increase in miR-183-5p and miR-182-5p expression, as well as a decrease in FOXO1 and miR-30d-5p expression, suggest that PTC has active autophagy machinery. This can possibly be used as a novel diagnostic or prognostic biomarker.
- 20 August 2021
- Published by Springer Nature in Research Square
Open AccessEstimation of Autophagy Activity By Evaluating Possible MicroRNA Biomarkers and FOXO1 mRNA Level in Papillary Thyroid Carcinoma
Background: Papillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy. Despite nearly three-fold increase in incidence over three decades, the mortality rate remains unchanged. Biomarkers related to early diagnosis and prognosis of PTC are poorly investigated. Autophagy pathways and related miRNAs is considered to play an important role in PTC pathophysiology.Methods and Results: Tissue samples from patients with PTC undergoing thyroidectomy were collected. Total RNA content of tumor and margin samples were purified and converted to cDNA. Gene expression levels of mRNA (FOXO1) and miRNAs (miR-30d-5p, miR- 182-5p and miR-183-5p) were evaluated using qPCR method in PTC and adjacent normal tissue. A 6.51-fold decrease in miR-30d-5p level was detected in tumor samples compared to adjacent tissues. Moreover, miR-182-5p and miR-183-5p (FOXO1 as the main target) showed 1.73- and 4.31-fold increases in their levels, respectively. We also observed a 2.66-fold decrease in FOXO1 mRNA level in relation to these miRNA fold changes indicating a possible correlation between autophagy-linked molecular events and PTC.Conclusions: Significant increase in miR-183-5p and miR-182-5p expression, as well as a decrease in FOXO1 and miR-30d-5p expression, suggest that PTC has active autophagy machinery. This can possibly be used as a novel diagnostic or prognostic biomarker.
- Open Access
- 1 September 2019
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 20 (9) , 2625-2631
Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia
Background: The key proliferative RTKs for AML include c-KIT receptor (CD117) and FLT-3 receptor (CD135).The aim of this study was to evaluate the CD135 and CD117 expression, co-expression of CD135 and CD117(CD135+CD117), and the association of that co-expression with Event Free Survival (DFS) and Overall Survival (OS)rates. Material and Methods: We analyzed CD117 and CD135 expression on AML blasts by flow cytometry and itsassociation with Event Free Survival (DFS) and Overall Survival (OS) in 66 AML treated on Hematology-OncologyResearch Center, Iran, Tabriz. Results: The overall OS and EFS were 50% and 80.3% respectively during our study.Cox-regression analysis revealed that a poor EFS was significantly associated a low CD135 (HR 0.34, 95% CI0.13–0.88, P = 0.02). Conclusion: This is the first study from Iran to show that the expressions of CD135, CD117 iseasily measurable by routine diagnostic flow-cytometry, and CD135+117 were not significantly associated with CR,EFS, or OS .
- 1 September 2019
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 20 (9) , 2625-2631
Open AccessRole of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia
Background: The key proliferative RTKs for AML include c-KIT receptor (CD117) and FLT-3 receptor (CD135).The aim of this study was to evaluate the CD135 and CD117 expression, co-expression of CD135 and CD117(CD135+CD117), and the association of that co-expression with Event Free Survival (DFS) and Overall Survival (OS)rates. Material and Methods: We analyzed CD117 and CD135 expression on AML blasts by flow cytometry and itsassociation with Event Free Survival (DFS) and Overall Survival (OS) in 66 AML treated on Hematology-OncologyResearch Center, Iran, Tabriz. Results: The overall OS and EFS were 50% and 80.3% respectively during our study.Cox-regression analysis revealed that a poor EFS was significantly associated a low CD135 (HR 0.34, 95% CI0.13–0.88, P = 0.02). Conclusion: This is the first study from Iran to show that the expressions of CD135, CD117 iseasily measurable by routine diagnostic flow-cytometry, and CD135+117 were not significantly associated with CR,EFS, or OS .
- Open Access
- 1 December 2018
- Published by Elsevier in Prostate International
- Vol. 6 (4) , 119-125
Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis
- 1 December 2018
- Published by Elsevier in Prostate International
- Vol. 6 (4) , 119-125
Open AccessDendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis